FDA Launches the Global Reliance Disclosure Program to Expand Patient Access to Medicines Worldwide
FDA today announced the Global Reliance Disclosure Program (GRDP), a landmark initiative that will fundamentally transform how the FDA's regulatory drug and biologic approval decisions are leveraged by health authorities around the world.
· Здоровье · Источник: U.S. Food and Drug Administration (FDA) · английский